Parkside Financial Bank & Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Buy
4,272
+232
+6% +$18.6K 0.02% 383
2025
Q4
$385K Sell
4,040
-283
-7% -$27.7K 0.03% 303
2025
Q3
$422K Sell
4,323
-213
-5% -$22.1K 0.03% 281
2025
Q2
$487K Buy
4,536
+1,142
+34% +$116K 0.05% 247
2025
Q1
$342K Buy
3,394
+253
+8% +$25.5K 0.04% 283
2024
Q4
$281K Sell
3,141
-492
-14% -$43.3K 0.04% 306
2024
Q3
$304K Buy
3,633
+50
+1% +$3.94K 0.04% 280
2024
Q2
$276K Buy
3,583
+45
+1% +$3.29K 0.04% 284
2024
Q1
$242K Buy
3,538
+285
+9% +$18.3K 0.04% 312
2023
Q4
$188K Sell
3,253
-229
-7% -$12.2K 0.03% 323
2023
Q3
$184K Buy
3,482
+627
+22% +$32.9K 0.04% 275
2023
Q2
$154K Sell
2,855
-22
-0.8% -$1.15K 0.04% 302
2023
Q1
$144K Buy
2,877
+121
+4% +$5.7K 0.04% 299
2022
Q4
$128K Buy
2,756
+1,142
+71% +$49.5K 0.04% 318
2022
Q3
$62K Sell
1,614
-115
-7% -$4.61K 0.02% 457
2022
Q2
$64K Sell
1,729
-64
-4% -$2.6K 0.02% 449
2022
Q1
$79K Buy
1,793
+306
+21% +$13.3K 0.02% 411
2021
Q4
$63K Sell
1,487
-47
-3% -$1.98K 0.02% 464
2021
Q3
$67K Buy
1,534
+47
+3% +$2.08K 0.02% 415
2021
Q2
$64K Buy
1,487
+111
+8% +$4.67K 0.02% 434
2021
Q1
$53K Buy
1,376
+100
+8% +$3.79K 0.02% 462
2020
Q4
$46K Sell
1,276
-669
-34% -$24.1K 0.01% 481
2020
Q3
$74K Sell
1,945
-52
-3% -$2K 0.03% 348
2020
Q2
$70K Buy
1,997
+54
+3% +$1.95K 0.02% 362
2020
Q1
$63K Sell
1,943
-175
-8% -$6.84K 0.02% 337
2019
Q4
$96K Sell
2,118
-33
-2% -$1.38K 0.03% 305
2019
Q3
$88K Sell
2,151
-12
-0.6% -$508 0.03% 298
2019
Q2
$93K Sell
2,163
-1
-0% -$38 0.03% 286
2019
Q1
$83K Sell
2,164
-721
-25% -$27.5K 0.03% 283
2018
Q4
$102K Buy
2,885
+1,721
+148% +$62.4K 0.04% 247
2018
Q3
$45K Buy
1,164
+117
+11% +$4.09K 0.02% 392
2018
Q2
$34K Buy
1,047
+112
+12% +$3.38K 0.01% 442
2018
Q1
$25K Buy
935
+218
+30% +$5.92K 0.01% 503
2017
Q4
$18K Sell
717
-261
-27% -$7.2K 0.01% 596
2017
Q3
$29K Buy
978
+154
+19% +$4.25K 0.01% 448
2017
Q2
$23K Buy
824
+210
+34% +$5.57K 0.01% 502
2017
Q1
$15K Buy
614
+59
+11% +$1.44K 0.01% 596
2016
Q4
$12K Sell
555
-166
-23% -$3.62K 0.01% 650
2016
Q3
$17K Buy
721
+41
+6% +$978 0.01% 601
2016
Q2
$16K Buy
680
+30
+5% +$649 0.01% 588
2016
Q1
$12K Buy
650
+514
+378% +$9.03K 0.01% 618
2015
Q4
$3K Buy
136
+31
+30% +$555 ﹤0.01% 832
2015
Q3
$2K Buy
+105
New +$1.79K ﹤0.01% 902

Other funds holding BSX

Parkside Financial Bank & Trust's BSX Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Boston Scientific (BSX) stake by 5.7% in Q1 2026, buying an estimated $18.6K and bringing the position to 4,272 shares worth $268K. The position accounts for 0.02% of the portfolio, ranked #383.

Parkside Financial Bank & Trust first reported a position in BSX in Q3 2015 and has held it in 43 quarters since. The position peaked at $487K in Q2 2025. 1,668 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Parkside Financial Bank & Trust held 4,272 shares of Boston Scientific worth $268K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 232 Boston Scientific shares in Q1 2026, an estimated $18.6K.
  • Boston Scientific made up 0.02% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #383 holding.
  • Parkside Financial Bank & Trust first reported a position in Boston Scientific in Q3 2015 and has held it in 43 quarters since.
  • Parkside Financial Bank & Trust's Boston Scientific position peaked at $487K in Q2 2025.
  • 1,668 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.